GNRH1 and prostate cancer: This prospective, multicenter, longitudinal, non‐interventional study, conducted in France, investigated the evolution of quality of life in patients with prostate cancer, and their partners, following initiation of GnRH agonist therapy, and examined the importance of relational cohesion.